Strategies to improve retention in randomised trials

K Gillies, A Kearney, C Keenan… - Cochrane Database …, 2021 - cochranelibrary.com
Background Poor retention of participants in randomised trials can lead to missing outcome
data which can introduce bias and reduce study power, affecting the generalisability, validity …

[HTML][HTML] The Alzheimer's Prevention Initiative Generation Program: study design of two randomized controlled trials for individuals at risk for clinical onset of …

CL Lopez, PN Tariot, A Caputo, JB Langbaum… - Alzheimer's & Dementia …, 2019 - Elsevier
Introduction Alzheimer's disease (AD) pathology, including the accumulation of amyloid beta
(Aβ) species and tau pathology, begins decades before the onset of cognitive impairment …

Increasing value and reducing waste: addressing inaccessible research

AW Chan, F Song, A Vickers, T Jefferson, K Dickersin… - The Lancet, 2014 - thelancet.com
The methods and results of health research are documented in study protocols, full study
reports (detailing all analyses), journal reports, and participant-level datasets. However …

[HTML][HTML] Blockchain technology for improving clinical research quality

M Benchoufi, P Ravaud - Trials, 2017 - Springer
Reproducibility, data sharing, personal data privacy concerns and patient enrolment in
clinical trials are huge medical challenges for contemporary clinical research. A new …

Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study

YX Chen, QY Gao, TH Zou, BM Wang… - The Lancet …, 2020 - thelancet.com
Background Chemoprevention of colorectal adenoma and colorectal cancer remains an
important public health goal. The present study aimed to investigate the clinical potential …

[HTML][HTML] Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis

E Mayo-Wilson, N Fusco, T Li, H Hong… - Journal of clinical …, 2017 - Elsevier
Objective To identify variations in outcomes and results across reports of randomized clinical
trials (RCTs). Study Design and Setting Eligible RCTs examined gabapentin for neuropathic …

Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed

Nature Medicine, 2019 - nature.com
Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed |
Nature Medicine Skip to main content Thank you for visiting nature.com. You are using a …

Artificial intelligence-powered blockchains for cardiovascular medicine

C Krittanawong, M Aydar, HUH Virk, A Kumar… - Canadian Journal of …, 2022 - Elsevier
Clinical databases, particularly those composed of big data, face growing security
challenges. Blockchain, the open, decentralized, distributed public ledger technology …

Blockchain technology applications for improving quality of electronic healthcare system

P Bhatt, S Singh, SK Sharma… - Blockchain for Healthcare …, 2021 - taylorfrancis.com
Blockchain technology has shown tremendous attention towards a plethora of maximum
applications ranging from data management, financial services, IoT, food security, and …

Quality standards for real-world research. Focus on observational database studies of comparative effectiveness

N Roche, H Reddel, R Martin, G Brusselle… - Annals of the …, 2014 - atsjournals.org
Real-world research can use observational or clinical trial designs, in both cases putting
emphasis on high external validity, to complement the classical efficacy randomized …